Zevra Therapeutics, Inc. ZVRA Interest Paid
Interest Paid at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestPaidNet.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s interest paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s interest paid?
- Zevra Therapeutics, Inc. (ZVRA) reported interest paid of $1.37M in Q1 2026.
- How has Zevra Therapeutics, Inc.'s interest paid changed year-over-year?
- Zevra Therapeutics, Inc.'s interest paid increased by 4.9% year-over-year, from $1.31M to $1.37M.
- What is the long-term trend for Zevra Therapeutics, Inc.'s interest paid?
- Over 4 years (2021 to 2025), Zevra Therapeutics, Inc.'s interest paid has grown at a 122.4% compound annual growth rate (CAGR), from $218K to $5.33M.
- What does interest paid mean?
- Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.